Odulimomab
Odulimomab
Odulimomab (pronunciation: /oʊˈduːlɪmoʊmæb/) is a type of monoclonal antibody used in the treatment of certain medical conditions.
Etymology
The term "Odulimomab" is derived from the International Nonproprietary Names (INN), where "o" signifies its mouse origin, "du" refers to the disease (tumor), "li" indicates the target (immune system), "mo" denotes its monoclonal nature, and "ab" stands for antibody.
Usage
Odulimomab is used in the treatment of cancer, specifically in the targeting of the CD3 receptor on T cells. It is a type of immunotherapy, which uses the body's immune system to fight disease.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Immunotherapy: A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.
- CD3 Receptor: A protein found on the surface of T cells that is involved in activating the immune response.
See Also
External links
- Medical encyclopedia article on Odulimomab
- Wikipedia's article - Odulimomab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski